05 May Transendocardial Cell Delivery In Post‑Acute Myocardial Infarction
Myocardial infarction (MI) remains a leading cause of heart failure worldwide despite major advances in reperfusion and pharmacologic therapy.
DRUG DELIVERY LEADER | Guest Column | May 4, 2026 – Ibon GARITAONANDIA, Ph.D, chief scientific officer, CellProthera